With many drugs in pharmaceutical industry pipelines showing solubility limitations, formulation of new drug candidates can be complex. This webinar describes approaches that streamline formulation and technology selection for compounds with low aqueous solubility and oral bioavailability. This compound-driven approach carefully matches the characteristics of the active ingredient and the target product profile to the best technology. An overview is provided of common bioavailability-enhancing technologies, including salts, polymorphs, cocrystals, nanocrystals, amorphous dispersions, and lipids. Also covered is the array of in vitro tests that can be used to evaluate bioavailability-enhancing formulations. Finally, three case studies are presented demonstrating the effectiveness of the approach in real-life application.